Cargando…
N(6)-methyladenosine (m(6)A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer
N(6)-methyladenosine (m(6)A) modification has been convincingly identified to be a critical regulator in human cancer. However, the contribution of m(6)A to NSCLC gefitinib resistance is still largely unknown. Here, we screened and identified that m(6)A methyltransferase KIAA1429 was highly expresse...
Autores principales: | Tang, Jun, Han, Tianci, Tong, Wei, Zhao, Jian, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128911/ https://www.ncbi.nlm.nih.gov/pubmed/34001850 http://dx.doi.org/10.1038/s41420-021-00488-y |
Ejemplares similares
-
N(6)-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner
por: Li, Ying, et al.
Publicado: (2022) -
N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression
por: Gan, Lijuan, et al.
Publicado: (2023) -
The biological function of m6A methyltransferase KIAA1429 and its role in human disease
por: Zhang, Xiaoyu, et al.
Publicado: (2022) -
m(6)A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis
por: Xu, Ke, et al.
Publicado: (2023) -
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
por: Lan, Tian, et al.
Publicado: (2019)